A Multi-Part, Phase I, Multi-Center, Open Label, Plus Expansion Clinical Trial of an Off-The-Shelf Neoantigen Heat Shock Protein Vaccine (rHSC-DIPGVax) in Combination with Checkpoint Blockade for the Treatment of Diffuse Intrinsic Pontine Glioma and Diffu